Neurocrine
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neurocrine and other ETFs, options, and stocks.About NBIX
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders.
CEOKevin Charles Gorman
CEOKevin Charles Gorman
Employees900
Employees900
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1992
Founded1992
Employees900
Employees900
NBIX Key Statistics
Market cap10.65B
Market cap10.65B
Price-Earnings ratio913.03
Price-Earnings ratio913.03
Dividend yield—
Dividend yield—
Average volume856.74K
Average volume856.74K
High today$111.78
High today$111.78
Low today$105.88
Low today$105.88
Open price$105.88
Open price$105.88
Volume978.66K
Volume978.66K
52 Week high$112.12
52 Week high$112.12
52 Week low$71.88
52 Week low$71.88
NBIX News
Investor's Business Daily 2d
Stocks Rally Again; Paylocity, On Semiconductor, Neurocrine Bio In Focus - Video - IBD - Investor's Business DailyOct 4, 2022|04:23 PM ET|ALISSA CORAM, JUSTIN NIELSEN There was plenty of bullish action in the market as stocks continued to move higher. The major indexes all...
Simply Wall St 2d
The 6.1% return this week takes Neurocrine Biosciences' shareholders five-year gains to 71% - Simply Wall StStock pickers are generally looking for stocks that will outperform the broader market. And the truth is, you can make significant gains if you buy good quality...
Investor's Business Daily 3d
Dow Jones Futures Advance As Treasury Yields Tumble; Apple, Tesla RallyDow Jones futures rallied more than 400 points Tuesday morning. Bonds also veered higher, driving down the 10-year Treasury yield. The major stock indexes appea...
Analyst ratings
59%
of 27 ratingsBuy
59.3%
Hold
37%
Sell
3.7%
NBIX Earnings
$0.00
$0.28
$0.56
$0.84
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated— per share
Estimated— per share
ActualExpected Nov 1, After Hours
ActualExpected Nov 1, After Hours
More NBIX News
Investor's Business Daily 3d
Vertex Among 9 Stocks To Watch In Struggling MarketAs the market correction continues, Vertex Pharmaceuticals (VRTX), Cardinal Health (CAH) and Cheniere Energy (LNG) are among a handful of stocks to watch showin...
